摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9-Hydroxy-6-methylnonanoic acid

中文名称
——
中文别名
——
英文名称
9-Hydroxy-6-methylnonanoic acid
英文别名
9-hydroxy-6-methylnonanoic acid
9-Hydroxy-6-methylnonanoic acid化学式
CAS
——
化学式
C10H20O3
mdl
——
分子量
188.26
InChiKey
KVWNTAPEFSVTQC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    13
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.9
  • 拓扑面积:
    57.5
  • 氢给体数:
    2
  • 氢受体数:
    3

文献信息

  • Substituted pyridyl-cycloalkyl-carboxylic acids, compositions containing them and medical uses thereof
    申请人:BAYER PHARMA AKTIENGESELLSCHAFT
    公开号:US10172814B2
    公开(公告)日:2019-01-08
    The present invention relates to substituted Pyridyl-cycloalkyl-carboxylic acids of general formula (I), to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular in mammals, such as diseases associated with pains, or for the treatment or prophylaxis of pain syndromes (acute and chronic), inflammatory-induced pain, pelvic pain, cancer-associated pain, endometriosis-associated pain as well as endometriosis and adenomyosis as such, cancer as such, and proliferative diseases as such like endometriosis.
    本发明涉及通式(I)的取代吡啶基-环烷基-羧酸、包含上述化合物的药物组合物和组合物,以及使用上述化合物制造药物组合物,用于治疗或预防疾病,尤其是哺乳动物的疾病、如与疼痛相关的疾病,或用于治疗或预防疼痛综合征(急性和慢性)、炎症引起的疼痛、盆腔疼痛、癌症相关疼痛、子宫内膜异位症相关疼痛以及子宫内膜异位症和子宫腺肌症、癌症以及子宫内膜异位症等增殖性疾病。
  • SUBSTITUTED PYRIDYL-CYCLOALKYL-CARBOXYLIC ACIDS, COMPOSITIONS CONTAINING THEM AND MEDICAL USES THEREOF
    申请人:BAYER PHARMA AKTIENGESELLSCHAFT
    公开号:US20170354620A1
    公开(公告)日:2017-12-14
    The present invention relates to substituted Pyridyl-cycloalkyl-carboxylic acids of general formula (I), to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular in mammals, such as diseases associated with pains, or for the treatment or prophylaxis of pain syndromes (acute and chronic), inflammatory-induced pain, pelvic pain, cancer-associated pain, endometriosis-associated pain as well as endometriosis and adenomyosis as such, cancer as such, and proliferative diseases as such like endometriosis.
  • [EN] PROCESS FOR THE EXTRACTION AND PURIFICATION OF LONG-CHAIN BI-FUNCTIONAL SUBERIN ACIDS FROM CORK<br/>[FR] PROCESSUS POUR L'EXTRACTION DU LIÈGE ET LA PURIFICATION D'ACIDES DE SUBÉRINE À DOUBLE FONCTION ET À LONGUE CHAÎNE
    申请人:INST SUPERIOR AGRONOMIA
    公开号:WO2014092591A1
    公开(公告)日:2014-06-19
    The present application describes a multi-step process for the isolation and purification of some of the main suberin acids from cork, based in solvent-fractionation and chromatographic techniques, affording these compounds in very-high purity, in excess of 99.5 %. Cork is first extracted with solvents and suberin is then depolymerised. The ensuing suberin acids mixtures are then partitioned using differential temperature and solvent-solubility precipitation. The fractions enriched in the different suberin acids thus obtained, are sequentially treated by medium-pressure normal phase chromatography (MPLC) and high-performance reversed-phase chromatography (HPLC), leading to individual suberin acid purities approaching 100 % purity. The process of the present invention is useful for several industrial applications to provide compounds which may be applied to pharmaceuticals, cosmetics, surfactants, engineering polymers, and bio-mimetic membranes.
查看更多